Expression and clinical implications of leucine‐rich repeat containing 15 (LRRC15) in osteosarcoma

Bioinformatics analysis of prognostic significance of COL10A1 in breast cancer

(2020) Mingdi Zhang et al.   BIOSCIENCE REPORTS

Emerging next-generation sequencing-based discoveries for targeted osteosarcoma therapy

(2020) Jie Zhao et al.   CANCER LETTERS

Cyclin E1 is a prognostic biomarker and potential therapeutic target in osteosarcoma

(2020) Ran Wei et al.   JOURNAL OF ORTHOPAEDIC RESEARCH

LRRC15 Targeting in Soft-Tissue Sarcomas: Biological and Clinical Implications

(2020) Eytan Ben-Ami et al.   Cancers

The Proteasome Inhibitor Ixazomib Inhibits the Formation and Growth of Pulmonary and Abdominal Osteosarcoma Metastases in Mice

(2020) Michael A. Harris et al.   Cancers

First-in-human phase 1 study of ABBV-085, an antibody-drug conjugate (ADC) targeting LRRC15, in sarcomas and other advanced solid tumors.

(2019) George D. Demetri et al.   JOURNAL OF CLINICAL ONCOLOGY

GENT2: an updated gene expression database for normal and tumor tissues

(2019) Seung-Jin Park et al.   BMC Medical Genomics

Genes associated with bowel metastases in ovarian cancer

(2019) Andrea Mariani et al.   GYNECOLOGIC ONCOLOGY

Advances in immune checkpoint inhibitors for bone sarcoma therapy

(2019) Pichaya Thanindratarn et al.   Journal of Bone Oncology

An update on emerging drugs in osteosarcoma: towards tailored therapies?

(2019) Claudia Maria Hattinger et al.   EXPERT OPINION ON EMERGING DRUGS

Transcriptional activation of CBFβ by CDK11p110 is necessary to promote osteosarcoma cell proliferation

(2019) Yong Feng et al.   Cell Communication and Signaling

Single-cell RNA sequencing reveals stromal evolution into LRRC15+ myofibroblasts as a determinant of patient response to cancer immunotherapy

(2019) Claudia X Dominguez et al.   Cancer Discovery

Chimeric antigen receptor T (CAR-T) cell immunotherapy for sarcomas: From mechanisms to potential clinical applications

(2019) Pichaya Thanindratarn et al.   CANCER TREATMENT REVIEWS

LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody–Drug Conjugates

(2018) James W. Purcell et al.   CANCER RESEARCH

Osteosarcoma, Chondrosarcoma, and Chordoma

(2018) Jeremy S. Whelan et al.   JOURNAL OF CLINICAL ONCOLOGY

Osteosarcoma: Accelerating Progress Makes for a Hopeful Future

(2018) Amanda J. Saraf et al.   Frontiers in Oncology

From genomics to metabolomics: emerging metastatic biomarkers in osteosarcoma

(2018) Dylan C. Dean et al.   CANCER AND METASTASIS REVIEWS

Current and future therapeutic approaches for osteosarcoma

(2017) Douglas J. Harrison et al.   Expert Review of Anticancer Therapy

Evaluation of P-glycoprotein (Pgp) expression in human osteosarcoma by high-throughput tissue microarray

(2016) Yan Gao et al.   JOURNAL OF ORTHOPAEDIC RESEARCH

Classifying Patients for Breast Cancer by Detection of Autoantibodies against a Panel of Conformation-Carrying Antigens

(2014) R. L. Evans et al.   Cancer Prevention Research

The Genotype-Tissue Expression (GTEx) project

(2013) John Lonsdale et al.   NATURE GENETICS

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

(2012) Jordi Barretina et al.   NATURE

Measurement of mRNA abundance using RNA-seq data: RPKM measure is inconsistent among samples

(2012) Günter P. Wagner et al.   THEORY IN BIOSCIENCES

Incidence, epidemiology and treatment results of osteosarcoma in Finland – a nationwide population-based study

(2011) Mika Sampo et al.   ACTA ONCOLOGICA

Osteosarcoma

(2010) Richard Gorlick et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Identification of brain- and bone-specific breast cancer metastasis genes

(2008) Andreas Klein et al.   CANCER LETTERS

The leucine-rich repeat structure

(2008) J. Bella et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Tumor Antigen LRRC15 Impedes Adenoviral Infection: Implications for Virus-Based Cancer Therapy

(2008) J. O'Prey et al.   JOURNAL OF VIROLOGY